or
forgot password
  • cancer clinical trials in lexington, KY

  • Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
    Markey Cancer Center at University of Kentucky Chandler Medical Center

    Trial Locations
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    John D. Cronin Cancer Center
    Head and Neck Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Kidney Cancer
    Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Breast Cancer
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia
    Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer
    Markey Cancer Center at University of Kentucky Chandler Medical Center
    Lexington, Kentucky 40536-0084
    Lung Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Central Baptist Hospital

    Trial Locations
    Central Baptist Hospital
    Lucille P. Markey Cancer Center at University of Kentucky
    Breast Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Central Baptist Hospital

    Trial Locations
    Central Baptist Hospital
    University of Kentucky
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Myeloid Leukemia, Chronic, Chronic-Phase
    Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Myeloid Leukemia, Chronic, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
    Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma
    VA Medical Center, Lexington
    Lexington, Kentucky 40502
    Prostate Cancer
    Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Localized Osteosarcoma, Metastatic Osteosarcoma
    Radiation Therapy in Treating Young Patients With Gliomas
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Brain Tumor, Central Nervous System Tumor
    Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer, Transitional Cell Carcinoma of the Bladder
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Colorectal Cancer
    Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Head and Neck Cancer
    Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia
    ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Neoplasms, Breast
    REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
    University of Kentucky Markey Cancer Center
    Lexington, Kentucky 40536
    Thyroid Neoplasms
    Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Prophylaxis for HPV Infections and Associated Cervical Neoplasia
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Hereditary Breast/Ovarian Cancer (brca1, brca2), Osteoporosis, Ovarian Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Central Baptist Hospital

    Trial Locations
    Central Baptist Hospital
    University of Kentucky
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Osteoporosis, Prostate Cancer
    PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Non Hodgkin Lymphoma
    Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Kidney Cancer
    Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Untreated Childhood Medulloblastoma, Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor
    Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, Adult Extraskeletal Chondrosarcoma, Adult Extraskeletal Osteosarcoma, Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, Adult Malignant Fibrous Histiocytoma, Adult Malignant Hemangiopericytoma, Adult Malignant Mesenchymoma, Adult Neurofibrosarcoma, Adult Synovial Sarcoma, Childhood Alveolar Soft-part Sarcoma, Childhood Angiosarcoma, Childhood Epithelioid Sarcoma, Childhood Fibrosarcoma, Childhood Leiomyosarcoma, Childhood Liposarcoma, Childhood Malignant Mesenchymoma, Childhood Neurofibrosarcoma, Childhood Synovial Sarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans, Localized Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Malignant Fibrous Histiocytoma of Bone, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific
    Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Adult Malignant Mesenchymoma, Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Childhood Malignant Mesenchymoma, Embryonal Childhood Rhabdomyosarcoma, Embryonal-botryoid Childhood Rhabdomyosarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma
    Bevacizumab, Radiation Therapy, and Cisplatin in Treating Patients With Previously Untreated Locally Advanced Cervical Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer
    Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia, Myelodysplastic Syndromes
    Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Leukemia
    Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Neoplasms, Breast
    Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Breast Cancer, Cognitive/Functional Effects, Lung Cancer, Metastatic Cancer, Prostate Cancer
    Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Stage III Wilms Tumor, Stage IV Wilms Tumor
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Central Baptist Hospital

    Trial Locations
    Central Baptist Hospital
    Lucille P. Markey Cancer Center at University of Kentucky
    Breast Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
    University of Kentucky
    Lexington, Kentucky 40536-0098
    Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, T-cell Adult Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Breast Cancer
    S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lung Cancer
    Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Cognitive/Functional Effects, Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    S0636: Erlotinib and Bevacizumab in Never-Smokers With Stage IIIB or Stage IV Primary Non-Small Cell Lung Cancer
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Lung Cancer
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Ovarian Cancer
    A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Lexington, Kentucky 40536
    Non-Small Cell Lung Cancer
    Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
    Lucille P. Markey Cancer Center at University of Kentucky
    Lexington, Kentucky 40536-0093
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Ovarian Cancer, Testicular Germ Cell Tumor
    GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
    GSK Investigational Site
    Lexington, Kentucky 40536-0098
    Lung Cancer, Non-Small Cell
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Central Baptist Hospital
    Lexington, Kentucky 40503
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific